![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Symbiotica Speciality Ingredients Sdn. Bhd. Butterworth My, based in Malaysia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Mometasone furoate monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-006 - Rev 00
This Chemical Type CEP, issued on February 08, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2858 associated with this CEP further emphasizes